Fully Ready to Operate as an Independent Company: Mongon

The video discusses Canview's first earnings announcement as a standalone company after its spin-off from Johnson & Johnson. The CEO, Tibo Mongol, highlights the company's strong performance, with 7.7% organic growth and $4 billion in revenue. Canview has improved its supply chain and is investing in advertising and partnerships. The company is ready to operate independently, despite Johnson & Johnson's significant shareholding. Canview is optimistic about its growth in China and the consumer health market, focusing on trusted brands like Neutrogena and Tylenol.

What is Canview's strategy regarding advertising and brand investment?

How does Canview perceive the current consumer spending trends in the United States?

What are Canview's projections for organic growth in 2023?